Trial
NCT03645876
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
SHR-1210
Why stopped
The study was terminated early due to company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-05-10